The inhibition of IKKε limited the inflammatory response in vivo and improved insulin sensitivity and glucose/lipid metabolism in patients with obesity and diabetes, which proposed a potential therapeutic approach. Here, IKBKE is linked to obesity due to melanocortin 4 receptor deficiency.